Breaking News
March 24, 2019 - Practices for Reducing COPD Hospital Readmissions Explored
March 24, 2019 - Could an eye doctor diagnose Alzheimer’s before you have symptoms?
March 24, 2019 - Enzyme inhibitor stops inflammation and neurodevelopmental disorders in mouse models
March 24, 2019 - Walk, Dance, Clean: Even a Little Activity Helps You Live Longer
March 24, 2019 - Americans used less eye care in 2014 versus 2008
March 24, 2019 - Study finds link between depression in 20s linked to memory loss in 50s
March 24, 2019 - New tool helps physiotherapy students to master complex fine motor skills
March 24, 2019 - The AMR Centre secures £2.3m funding boost
March 24, 2019 - Study examines effects of taking ondansetron during first trimester of pregnancy
March 24, 2019 - Researchers identify a more effective treatment for cancer
March 24, 2019 - Open-source solution for multiparametric optical mapping of the heart’s electrical activity
March 24, 2019 - New nanotechnology approach shows promise in treating triple negative breast cancer
March 24, 2019 - Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
March 24, 2019 - Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
March 24, 2019 - Apple watch could detect irregular heart beat says study
March 24, 2019 - Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
March 24, 2019 - Girls should be encouraged to gain more ball skills, shows study
March 24, 2019 - Acute doses of synthetic cannabinoid can impair critical thinking and memory
March 24, 2019 - Presence of bacteria in urine does not always point to infection, shows study
March 24, 2019 - Scientists identify a new role for nerve-supporting cells
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials

Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials

image_pdfDownload PDFimage_print

Action Points

  • Note that this meta-analysis suggests that increased use of guideline-directed medical therapy in patients undergoing PCI compared to CABG might explain part of the observed benefit of the former therapy.
  • Future studies evaluating CABG, in particular, should be sure to capture medication prescriptions and adherence postoperatively.

Adherence to medical therapy for secondary prevention was generally low in trials comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) and may have even inadvertently given stenting an advantage in these clinical studies, according to a meta-analysis of large clinical trials.

Guideline-directed medical therapy (GDMT) in terms of the combination treatment with antiplatelets, beta-blockers, and statins was prescribed to 67% at year 1 after coronary revascularization and 53% at year 5. Compliance fell even lower — 40% at year 1 and 38% at year 5 — when the recommended treatment list included the use of ACE inhibitors or angiotensin receptor blockers (ARBs).

“Despite the compelling benefits demonstrated by GDMT as secondary prevention after coronary revascularization, compliance remains low even in the tightly controlled environment of clinical trials,” Ana-Catarina Pinho-Gomes, MSc, of Oxford’s John Radcliffe Hospital in England, and colleagues wrote in the Feb. 13 issue of the Journal of the American College of Cardiology.

Notably, adherence to the guidelines was consistently lower after CABG than with PCI. “The difference was particularly marked for P2Y12-receptor inhibitors, as dual antiplatelet therapy is formally recommended in the guidelines after PCI,” the researchers noted.

“The better outcomes achieved with CABG versus PCI became less obvious as the compliance with GDMT increased in PCI versus CABG. Therefore, if compliance rates were identical in both groups, the superiority of CABG for major clinical endpoints might have been even more marked, as part of the benefit of PCI might be explained by better compliance with GDMT,” the investigators suggested.

Their meta-analysis included five trials: SYNTAX, FREEDOM, PRECOMBAT, BEST, and EXCEL.

Pinho-Gomes’ group said that the underuse of GDMT, particularly after CABG, may be related to the misconception that the value of maintaining GDMT is reduced once diseased coronary arteries have been mechanically revascularized with either PCI or CABG.

“In keeping with this, medical therapy is often neglected in coronary revascularization trials and hence poorly reported or not even collected at all, as happened in the recent NOBLE trial,” they pointed out.

“From a research perspective, going forward, clinical investigators must direct their energy toward collecting prescription data in [coronary artery disease] trials and strive to implement GDMT for nearly all study subjects. As leaders in the field and frequent co-authors of guideline statements, revascularization trialists have a responsibility to serve as role models in improving GDMT prescription rates,” said Marc Ruel, MD, MPH, of the University of Ottawa Heart Institute in Ontario, and Alexander Kulik, MD, MPH, of Boca Raton Regional Hospital in Florida.

In an accompanying editorial, Ruel and Kulik suggested that this must be done, even if it means providing trial participants with full coverage for secondary prevention therapy. “Ultimately, improving compliance with GDMT both in and out of the clinical trial context will help our patients achieve the highest level of physical health and quality of life after coronary revascularization,” they said.

Pinho-Gomes and colleagues noted that overall compliance with aspirin and statins was high and reasonably stable over time. There were some differences in antiplatelet prescribing patterns — but considering the controversy regarding dual antiplatelet therapy after coronary revascularization, these differences between trials were not unexpected, either.

It was compliance with beta-blockers and ACE inhibitors or ARBs that was low and more variable, ranging from 43% to 80% and 28% to 79%, respectively, in trials.

“One possible explanation is the fact that although the efficacy of antiplatelet agents and statins in reducing cardiovascular events after coronary revascularization has long been recognized, the advantages of other drug classes have been established more recently and may vary according to comorbidities and risk factors,” the authors suggested.

Limitations of the meta-analysis were that it potentially overestimated medication compliance, because prescriptions were analyzed as a surrogate endpoint; that no patient-level data were available for analysis; and that relatively few trials were included.

Pinho-Gomes and Ruel disclosed no conflicts of interest.

Kulik reported research support from AstraZeneca and Pfizer.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-06-02T00:00:00-0400

last updated

Tagged with:

About author

Related Articles